UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway

Cell death & disease, 2020-04, Vol.11 (4), p.273-273, Article 273

2020

Volltextzugriff (PDF)

UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370

Cancer cell international, 2020-01, Vol.20 (1), p.3-3, Article 3

2020

Volltextzugriff (PDF)

CBX2 is a functional target of miRNA let‐7a and acts as a tumor promoter in osteosarcoma

Cancer medicine (Malden, MA), 2019-07, Vol.8 (8), p.3981-3991

2019

Volltextzugriff (PDF)

Anti-CD22 Calicheamicin-Inotuzumab Ozogamicin Combined with Venetoclax + Azacitidine in the Treatment of Mixed-Phenotype Acute Leukemia: A Case Report

Turkish journal of haematology, 2024-09, Vol.41 (3), p.202-204

2024

Volltextzugriff (PDF)

PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Scientific reports, 2017-06, Vol.7 (1), p.2894-14, Article 2894

2017

Volltextzugriff (PDF)

Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear target

Journal of translational medicine, 2014-06, Vol.12 (1), p.167-167, Article 167

2014

Volltextzugriff (PDF)

A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With SF3B1 Mutation

Frontiers in oncology, 2022-06, Vol.12, p.905490-905490

2022

Volltextzugriff (PDF)

Primary refractory diffuse large B-cell lymphoma of the uterine cervix metastasizing to the kidney: A case report

Asian journal of surgery, 2024-09, Vol.47 (9), p.4013-4015

2024

Volltextzugriff (PDF)

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

Blood, 2022-11, Vol.140 (Supplement 1), p.9796-9797

2022

Volltextzugriff (PDF)

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of the EB Subtype of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

Blood, 2023-11, Vol.142 (Supplement 1), p.6481-6481

2023

Volltextzugriff (PDF)

Blockade of de novo pyrimidine biosynthesis triggers autophagic degradation of oncoprotein FLT3-ITD in acute myeloid leukemia

Oncogene, 2023-11, Vol.42 (45), p.3331-3343

2023

Volltextzugriff (PDF)

Anti-CD22 Calecheamicin-Inotuzumab Ozogamicin Combined with Venetoclax + Azatabine in the Treatment of Mixed Phenotype Acute Leukemia: A Case Report

Turkish journal of haematology, 2024-07

2024

Volltextzugriff (PDF)

All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex

British journal of cancer, 2023-02, Vol.128 (4), p.691-701

2023

Volltextzugriff (PDF)

High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia

Aging (Albany, NY.), 2021-04, Vol.13 (8), p.11988-12006

2021

Volltextzugriff (PDF)

Modified cladribine, cytarabine, and G-CSF as a salvage regimen in patients with relapsed/refractory acute myeloid leukemia: a bridge to myeloablative allogeneic hematopoietic stem cell transplantation

Annals of hematology, 2019-09, Vol.98 (9), p.2073-2080

2019

Volltextzugriff (PDF)

Epigenetic Priming with Decitabine Followed By Low-Dose Idarubicin Plus Cytarabine in AML Evolving from MDS or Higher Risk MDS: A Multicentre Phase 2 Single-Arm Trial

Blood, 2019-11, Vol.134 (Supplement_1), p.2594-2594

2019

Volltextzugriff (PDF)

High expression of long non-coding RNA NNT-AS1 facilitates progression of cholangiocarcinoma through promoting epithelial-mesenchymal transition

American journal of translational research, 2019-01, Vol.11 (9), p.5438-5456

2019

Volltextzugriff (PDF)

RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cells

Science advances, 2024-04, Vol.10 (16), p.eadi1782-eadi1782

2024

Volltextzugriff (PDF)

Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher‐risk myelodysplastic syndromes: a prospective multicenter single‐arm trial

Hematological oncology, 2020-10, Vol.38 (4), p.531-540

2020

Volltextzugriff (PDF)

Synergistic Effect of Sequential Combination of Decitabine and Idarubicin in Mouse Model of Human Acute Myeloid Leukemia

Blood, 2012-11, Vol.120 (21), p.1515-1515

2012

Volltextzugriff (PDF)

Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Scientific reports, 2017-11, Vol.7 (1), p.15260-1, Article 15260

2017

Volltextzugriff (PDF)

Methylation Analysis of the Wnt Antagonist in Myelodysplastic Syndrome

Blood, 2011-11, Vol.118 (21), p.5048-5048

2011

Volltextzugriff (PDF)

Synergistic Depression of Wnt Pathway by Sequential Combination of Decitabine and Idarubicin in Human Myeloid Leukemic Cell Lines

Blood, 2011-11, Vol.118 (21), p.3628-3628

2011

Volltextzugriff (PDF)

Expression of the Hypoxia-Inducible Factors In the AML and MDS: Is Not Associated with the Von Hippel-Lindau Gene

Blood, 2010-11, Vol.116 (21), p.5114-5114

2010

Volltextzugriff (PDF)

Arsenic trioxide may improve the prognosis of APL with ider(17)(q10): report of a rare adult case of acute promyelocytic leukemia with ider(17)(q10)t(15;17) showing poor response to all-trans retinoic acid

Annals of hematology, 2011-12, Vol.90 (12), p.1493-1494

2011

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway

UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370

CBX2 is a functional target of miRNA let‐7a and acts as a tumor promoter in osteosarcoma

Anti-CD22 Calicheamicin-Inotuzumab Ozogamicin Combined with Venetoclax + Azacitidine in the Treatment of Mixed-Phenotype Acute Leukemia: A Case Report

PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear target

A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With SF3B1 Mutation

Primary refractory diffuse large B-cell lymphoma of the uterine cervix metastasizing to the kidney: A case report

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of the EB Subtype of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

Blockade of de novo pyrimidine biosynthesis triggers autophagic degradation of oncoprotein FLT3-ITD in acute myeloid leukemia

Anti-CD22 Calecheamicin-Inotuzumab Ozogamicin Combined with Venetoclax + Azatabine in the Treatment of Mixed Phenotype Acute Leukemia: A Case Report

All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex

High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia

Modified cladribine, cytarabine, and G-CSF as a salvage regimen in patients with relapsed/refractory acute myeloid leukemia: a bridge to myeloablative allogeneic hematopoietic stem cell transplantation

Epigenetic Priming with Decitabine Followed By Low-Dose Idarubicin Plus Cytarabine in AML Evolving from MDS or Higher Risk MDS: A Multicentre Phase 2 Single-Arm Trial

High expression of long non-coding RNA NNT-AS1 facilitates progression of cholangiocarcinoma through promoting epithelial-mesenchymal transition

RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cells

Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher‐risk myelodysplastic syndromes: a prospective multicenter single‐arm trial

Synergistic Effect of Sequential Combination of Decitabine and Idarubicin in Mouse Model of Human Acute Myeloid Leukemia

Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Methylation Analysis of the Wnt Antagonist in Myelodysplastic Syndrome

Synergistic Depression of Wnt Pathway by Sequential Combination of Decitabine and Idarubicin in Human Myeloid Leukemic Cell Lines

Expression of the Hypoxia-Inducible Factors In the AML and MDS: Is Not Associated with the Von Hippel-Lindau Gene

Arsenic trioxide may improve the prognosis of APL with ider(17)(q10): report of a rare adult case of acute promyelocytic leukemia with ider(17)(q10)t(15;17) showing poor response to all-trans retinoic acid

Suchergebnisse filtern